- Home
- PMCB vs NCRA Comparison
PMCB vs NCRA Comparison
Compare PMCB & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- NCRA
- Stock Information
- Founded
- PMCB 1996
- NCRA 2002
- Country
- PMCB United States
- NCRA Taiwan
- Employees
- PMCB 2
- NCRA N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- NCRA Farming/Seeds/Milling
- Sector
- PMCB Health Care
- NCRA Consumer Staples
- Exchange
- PMCB Nasdaq
- NCRA Nasdaq
- Market Cap
- PMCB 11.4M
- NCRA 12.6M
- IPO Year
- PMCB N/A
- NCRA N/A
- Fundamental
- Price
- PMCB $1.64
- NCRA $0.82
- Analyst Decision
- PMCB
- NCRA
- Analyst Count
- PMCB 0
- NCRA 0
- Target Price
- PMCB N/A
- NCRA N/A
- AVG Volume (30 Days)
- PMCB 14.0K
- NCRA 8.2K
- Earning Date
- PMCB 12-24-2024
- NCRA 08-14-2024
- Dividend Yield
- PMCB N/A
- NCRA N/A
- EPS Growth
- PMCB N/A
- NCRA N/A
- EPS
- PMCB 0.74
- NCRA N/A
- Revenue
- PMCB N/A
- NCRA $20,483,694.00
- Revenue This Year
- PMCB N/A
- NCRA N/A
- Revenue Next Year
- PMCB N/A
- NCRA N/A
- P/E Ratio
- PMCB $2.21
- NCRA N/A
- Revenue Growth
- PMCB N/A
- NCRA N/A
- 52 Week Low
- PMCB $1.39
- NCRA $0.70
- 52 Week High
- PMCB $2.58
- NCRA $1.54
- Technical
- Relative Strength Index (RSI)
- PMCB 45.24
- NCRA 41.47
- Support Level
- PMCB $1.60
- NCRA $0.76
- Resistance Level
- PMCB $1.69
- NCRA $1.14
- Average True Range (ATR)
- PMCB 0.11
- NCRA 0.11
- MACD
- PMCB -0.00
- NCRA -0.01
- Stochastic Oscillator
- PMCB 40.00
- NCRA 35.82
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.